diagnostic and pharmaceutical products.
United States of America
Ian Gilham was appointed as a Non-Executive Director on 1 July 2015. Ian was appointed Chairman of the Remuneration Committee on 1 July 2015. Ian has international experience in the research, development and commercialisation of diagnostic and pharmaceutical products. Ian is Non-Executive Chairman of a number of UK and European companies including Epistem Holdings Limited, Concepta Diagnostics Limited, Horizon Discovery Group plc, Multiplicom NV, and Biosurfit SA. Ian was formerly CEO of Axis-Sheild plc, a FTSE listed global diagnostics company which was sold to Alere Inc for £260 million in 2011. Ian also previously worked at GlaxoSmithKline as Vice President - Pharmacogenetics and before that held international general management, marketing business development and R&D positions with Abbott Laboratories, Celltech and Amersham. Ian holds a Life Sciences PhD from the University of Bath.
Diagnostic and pharmaceutical products